ObvioHealth: data partnership with Dedalus
Virtual research organization has expanded its tech alliance with Dedalus Group to include global licensing of Dedalus’s technology. This new agreement grants ObvioHealth use of Dedalus’s data mining and analytics tools for their own research, and for that of its partners and sponsors.
This technology reportedly will enable access to analytics of ObvioHealth’s own multi-source healthcare data to inform better clinical trial design and recruitment as well as longitudinal disease and treatment trends. Partner sites and their providers will also be able to propose clinical trials to their patients, a key area of opportunity given a recent WRG Market Analysis indicating that only 3% of physicians and 5% of patients currently participate in clinical trials; the data also reportedly will help train AI-enabled digital and diagnostic instruments to provide deeper analysis of certain disease states.